Key Points
- CEO Grigorios Siokas bought 55,732 shares on Nov. 25 at $0.63 for $35,111.16 as part of a multi-day buying spree (Nov. 19–21 and 25) that added 224,741 shares total and raised his holdings to 6,383,625 shares (a ~0.88% increase, ~ $4.02M value).
- Cosmos Health shares traded at $0.63 (+0.9%) on heavy volume, but the company remains small and volatile (market cap $22.1M, beta 5.32) and reported Q3 EPS of −$0.17 (missing estimates) with negative margins and a forecasted full-year EPS around −0.78.
- Market sentiment is weak (average analyst rating "Sell"), although Citadel Advisors boosted its stake by 133% to 225,507 shares, indicating some institutional buying interest.
Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas bought 55,732 shares of Cosmos Health stock in a transaction on Tuesday, November 25th. The shares were purchased at an average price of $0.63 per share, for a total transaction of $35,111.16. Following the acquisition, the chief executive officer directly owned 6,383,625 shares in the company, valued at approximately $4,021,683.75. This trade represents a 0.88% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink.
Grigorios Siokas also recently made the following trade(s):
- On Friday, November 21st, Grigorios Siokas purchased 56,080 shares of Cosmos Health stock. The shares were purchased at an average price of $0.68 per share, for a total transaction of $38,134.40.
- On Thursday, November 20th, Grigorios Siokas purchased 51,315 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.62 per share, for a total transaction of $31,815.30.
- On Wednesday, November 19th, Grigorios Siokas acquired 61,614 shares of Cosmos Health stock. The stock was purchased at an average price of $0.65 per share, with a total value of $40,049.10.
Cosmos Health Stock Up 0.9%
Cosmos Health stock traded up $0.01 on Thursday, hitting $0.63. 797,226 shares of the stock traded hands, compared to its average volume of 394,947. Cosmos Health Inc. has a 1 year low of $0.28 and a 1 year high of $1.32. The firm has a market cap of $22.12 million, a P/E ratio of -0.84 and a beta of 5.32. The company has a current ratio of 0.99, a quick ratio of 0.84 and a debt-to-equity ratio of 0.25. The business's fifty day simple moving average is $0.91 and its 200 day simple moving average is $0.72.
Cosmos Health (NASDAQ:COSM - Get Free Report) last issued its quarterly earnings results on Friday, November 14th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.16). Cosmos Health had a negative return on equity of 33.19% and a negative net margin of 31.01%.The business had revenue of $17.11 million during the quarter, compared to the consensus estimate of $16.40 million. As a group, sell-side analysts forecast that Cosmos Health Inc. will post -0.78 earnings per share for the current year.
Wall Street Analyst Weigh In
A number of brokerages have recently commented on COSM. Wall Street Zen raised Cosmos Health to a "hold" rating in a research report on Saturday, September 20th. Weiss Ratings reissued a "sell (d-)" rating on shares of Cosmos Health in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has an average rating of "Sell".
Read Our Latest Analysis on COSM
Hedge Funds Weigh In On Cosmos Health
A hedge fund recently raised its stake in Cosmos Health stock. Citadel Advisors LLC increased its holdings in Cosmos Health Inc. (NASDAQ:COSM - Free Report) by 133.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 225,507 shares of the company's stock after buying an additional 128,776 shares during the quarter. Citadel Advisors LLC owned 0.65% of Cosmos Health worth $250,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 12.61% of the company's stock.
About Cosmos Health
(
Get Free Report)
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
